Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009951
Filing Date
2016-11-10
Accepted
2016-11-10 16:53:30
Documents
55
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20160930x10q.htm 10-Q 1623736
2 EX-10.1 bpmc-20160930ex101983993.htm EX-10.1 53782
3 EX-10.2 bpmc-20160930ex102db01b5.htm EX-10.2 577766
4 EX-10.3 bpmc-20160930ex1035083d6.htm EX-10.3 103909
5 EX-31.1 bpmc-20160930ex31162465e.htm EX-31.1 18024
6 EX-31.2 bpmc-20160930ex312304072.htm EX-31.2 18079
7 EX-32.1 bpmc-20160930ex321c668e1.htm EX-32.1 13897
  Complete submission text file 0001558370-16-009951.txt   5959011

Data Files

Seq Description Document Type Size
8 EX-101.INS bpmc-20160930.xml EX-101.INS 897181
9 EX-101.SCH bpmc-20160930.xsd EX-101.SCH 41945
10 EX-101.CAL bpmc-20160930_cal.xml EX-101.CAL 44663
11 EX-101.DEF bpmc-20160930_def.xml EX-101.DEF 157918
12 EX-101.LAB bpmc-20160930_lab.xml EX-101.LAB 423886
13 EX-101.PRE bpmc-20160930_pre.xml EX-101.PRE 279591
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 161988786
SIC: 2834 Pharmaceutical Preparations